Consumers who hoped to rid themselves of the common cold by taking the herbal remedy Airborne can receive a refund from the company; it is being reported by ABC News.

Airborne will settle a class action lawsuit and pay $23.3. million due to false advertising after claiming it was “the miracle cold buster.”

"You can say your product prevents or cures the common cold if you have data to support that," said Ronald Turner, professor of pediatrics and associate dean for clinical research at the University of Virginia School of Medicine. "What happened with Airborne is that they made the claim, but had no data."

Click here to read the full story from ABC News.